CLINICAL IMPACT OF DOSE MODIFICATION AND DOSE INTENSITY ON RESPONSE TO PONATINIB IN PATIENTS (PTS) WITH PHILADELPHIA CHROMOSOME-POSITIVE (PH plus ) LEUKEMIAS

被引：0

作者：

Nicolini, F. E. ^{[1
]}

Cortes, J. E. ^{[2
]}

Kim, D. W. ^{[3
]}

Pinilla-Ibarz, J. ^{[4
]}

le Coutre, P. D. ^{[5
]}

Paquette, R. ^{[6
]}

Chuah, C. ^{[7
]}

Apperley, J. F. ^{[8
]}

Khoury, H. J. ^{[9
]}

Talpaz, M. ^{[10
]}

DiPersio, J. F. ^{[11
]}

DeAngelo, D. J. ^{[12
]}

Abruzzese, E. ^{[13
]}

Rea, D. ^{[14
,15
]}

Baccarani, M. ^{[16
]}

Muller, M. C. ^{[17
]}

Gambacorti-Passerini, C. ^{[18
]}

Lustgarten, S. ^{[19
]}

Rivera, V. M. ^{[19
]}

Haluska, F. G. ^{[19
]}

Guilhot, F. ^{[20
]}

Deininger, M. W. ^{[21
]}

Hughes, T. P. ^{[22
]}

Shah, N. P. ^{[23
]}

Kantarjian, H. M. ^{[2
]}

Hochhaus, A. ^{[24
]}

机构：

[1] Ctr Hosp Lyon Sud, F-69310 Pierre Benite, France

[2] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA

[3] Catholic Univ Korea, Seoul St Marys Hosp, Seoul, South Korea

[4] Univ S Florida, H Lee Moffitt Canc Ctr, Tampa, FL 33682 USA

[5] Charite, D-13353 Berlin, Germany

[6] Univ Calif Los Angeles, Ronald Reagan UCLA Med Ctr, Los Angeles, CA USA

[7] Singapore Gen Hosp, Duke NUS Grad Med Sch, Singapore, Singapore

[8] Univ London Imperial Coll Sci Technol & Med, London, England

[9] Emory Univ, Winship Canc Inst, Atlanta, GA 30322 USA

[10] Univ Michigan, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA

[11] Washington Univ, Sch Med, St Louis, MO USA

[12] Dana Farber Canc Inst, Boston, MA 02115 USA

[13] Univ Roma Tor Vergata, S Eugenio Hosp, Rome, Italy

[14] Hop St Louis, Serv Malad Sang, Paris, France

[15] Hop St Louis, CIC Clin Invest Ctr, Paris, France

[16] S Orsola Malpighi Univ Hosp, Bologna, Italy

[17] Univ Med, Med Klin 3, Mannheim, Germany

[18] Azienda Osped San Gerardo Univ Milano Bicocca, Unita Ric Clin Ematol, Monza, Italy

[19] ARIAD Pharmaceut Inc, Cambridge, MA USA

[20] Univ Hosp, CHU Poitiers, Poitiers, France

[21] Univ Utah, Huntsman Canc Inst, Salt Lake City, UT USA

[22] Inst Med & Vet Sci, Adelaide, SA 5000, Australia

[23] Univ Calif San Francisco, San Francisco, CA 94143 USA

[24] Univ Klinikum Jena, Jena, Germany

来源：

HAEMATOLOGICA | 2014年 / 99卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

P894

引用

页码：334 / 334

页数：1

共 50 条

[41] Clinical outcomes in patients with Philadelphia chromosome-positive leukemia treated with ponatinib in routine clinical practice-data from a Belgian registry
Devos, Timothy
Havelange, Violaine
Theunissen, Koen
Meers, Stef
Benghiat, Fleur Samantha
Gadisseur, Alain
Vanstraelen, Gaetan
Vellemans, Helene
Bailly, Benjamin
Granacher, Nikki
Lewalle, Philippe
De Becker, Ann
Van Eygen, Koen
Janssen, Mia
Triffet, Agnes
Vrelust, Inge
Deeren, Dries
Mazure, Dominiek
Bekaert, Julie
Beck, Michael
Selleslag, Dominik
ANNALS OF HEMATOLOGY, 2021, 100 (07) : 1723 - 1732
[42] Clinical and hematological remission after a single dose of mitoxantrone in a child with Philadelphia chromosome-positive chronic myeloid leukemia
Oner, AF
Hicsonmez, G
Olcay, L
PEDIATRIC HEMATOLOGY AND ONCOLOGY, 1997, 14 (05) : 483 - 486
[43] Ponatinib in Pediatric Patients with Philadelphia Chromosome-Positive Leukemia - Japanese Pediatric Leukemia/Lymphoma Study Group
Kodama, Yuichi
Sato, Atsushi
Kato, Keisuke
Kato, Motohiro
Kawasaki, Hirohide
Sakaguchi, Hirotoshi
Hiramatsu, Hidefumi
Kato, Itaru
Taga, Takashi
Shimada, Hiroyuki
PEDIATRIC BLOOD & CANCER, 2020, 67
[44] Impact of complete molecular response on survival in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia
Short, Nicholas J.
Jabbour, Elias
Sasaki, Koji
Patel, Keyur
O'Brien, Susan M.
Cortes, Jorge E.
Garris, Rebecca
Issa, Ghayas C.
Garcia-Manero, Guillermo
Luthra, Rajyalakshmi
Thomas, Deborah
Kantarjian, Hagop
Ravandi, Farhad
BLOOD, 2016, 128 (04) : 504 - 507
[45] A phase II trial of a chemotherapy-free combination of ponatinib and blinatumomab in adults with Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph plus ALL).
Short, Nicholas James
Kantarjian, Hagop M.
Konopleva, Marina
Bravo, Guillermo Montalban
Ravandi, Farhad
Jain, Nitin
Kadia, Tapan M.
Valero, Yesid Alvarado
Chien, Kelly Sharon
Daver, Naval Guastad
Macaron, Walid
Sasaki, Koji
Thankachan, Jennifer
Delumpa, Ricardo
Mayor, Ejiroghene
Deen, Wuliamatu
Loiselle, Christopher
Kwari, Monica
Garris, Rebecca
Jabbour, Elias
JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
[46] Prognostic Significance of the Lost of a Major Molecular Response In Philadelphia Chromosome-Positive Chronic Myelogenous Leukemia (Ph plus CML)
Valentin Garcia-Gutierrez, J.
Herrera, Pilar
Jimenez-Rolando, Marta
Tenorio, Maria
Calbacho, Maria
Jesus Blanchard, M.
Dolores Rey, Maria
Ramos, Paloma
Ramos, M. L.
Lopez, Javier
BLOOD, 2010, 116 (21) : 1408 - 1408
[47] Phase 3 PhALLCON study: Ponatinib (PON) versus imatinib (IM) with reduced-intensity chemotherapy (CT) in patients (pts) with newly diagnosed Philadelphia chromosome positive (Ph plus ) ALL.
Jabbour, Elias
Martinelli, Giovanni
Vignetti, Marco
Ribera, Josep-Maria
Gomez-Almaguer, David
Minami, Yosuke
Xu, Jing
Srivastava, Shouryadeep
Neumann, Frank
Kantarjian, Hagop M.
JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
[48] PONATINIB IN PATIENTS (PTS) WITH PHILADELPHIA CHROMOSOME- POSITIVE (PH plus ) LEUKEMIAS RESISTANT OR INTOLERANT TO DASATINIB OR NILOTINIB, OR WITH THE T315I MUTATION: LONGER-TERM FOLLOW-UP OF THE PACE TRIAL
le Coutre, P. D.
Kim, D. W.
Pinilla-Ibarz, J.
Paquette, R.
Chuah, C.
Nicolini, F. E.
Apperley, J. F.
Khoury, H. J.
Talpaz, M.
DiPersio, J. F.
DeAngelo, D.
Abruzzese, E.
Rea, D.
Baccarani, M.
Muller, M.
Gambacorti-Passerini, C.
Lustgarten, S.
Haluska, F. G.
Guilhot, F.
Deininger, M. W.
Hochhaus, A.
Hughes, T. P.
Shah, N. P.
Kantarjian, H. M.
Cortes, J. E.
HAEMATOLOGICA, 2014, 99 : 334 - 334
[49] Overall Survival With Ponatinib Versus Allogeneic Stem Cell Transplantation in Philadelphia Chromosome-Positive Leukemias With the T315I Mutation
Nicolini, Franck E.
Basak, Grzegorz W.
Kim, Dong-Wook
Olavarria, Eduardo
Pinilla-Ibarz, Javier
Apperley, Jane F.
Hughes, Timothy
Niederwieser, Dietger
Mauro, Michael J.
Chuah, Charles
Hochhaus, Andreas
Martinelli, Giovanni
DerSarkissian, Maral
Duh, Mei Sheng
McGarry, Lisa J.
Kantarjian, Hagop M.
Cortes, Jorge E.
CANCER, 2017, 123 (15) : 2875 - 2880
[50] Update of Olverembatinib (HQP1351) Overcoming Ponatinib and/or Asciminib Resistance in Patients (Pts) with Heavily Pretreated/Refractory Chronic Myeloid Leukemia (CML) and Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (Ph plus ALL)
Jabbour, Panelelias
Kantarjian, Hagop M.
Koller, Paul B.
Jamy, Omer
Oehler, Vivian G.
Lomaia, Elza
Hunter, Anthony M.
Uspenskaya, Olga
Samarina, Svetlana
Mukherjee, Sudipto
Baer, Maria R.
Zherebtsova, Vera
Shuvaev, Vasily
Turkina, Anna
Davydkin, Igor
Cortes, Jorge
Guo, Huanshan
Chen, Zi
Fu, Lei
Wang, Hengbang
Jiang, Lixin
Wang, Cunlin
Yang, Dajun
Zhai, Yifan
BLOOD, 2023, 142

← 1 2 3 4 5 →